Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries

Autor: Irene K. Veldhuijzen, Abby Falla, Teymur Noori, Ralf Reintjes, Erika Duffell, Angela Bechini, Amena Ahmad
Přispěvatelé: Public Health
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Hepatitis B virus
medicine.medical_specialty
Epidemiology
Population
Migrants
lcsh:Infectious and parasitic diseases
03 medical and health sciences
Hepatitis B
Chronic
0302 clinical medicine
SDG 3 - Good Health and Well-being
Chronic hepatitis
medicine
Humans
media_common.cataloged_instance
Chronic viral hepatitis
Targeted screening
lcsh:RC109-216
European Union
030212 general & internal medicine
European union
China
education
media_common
Transients and Migrants
education.field_of_study
Hepatitis B Surface Antigens
Hepatitis B
Chronic viral hepatitis
Migrants
Epidemiology
Europe
social sciences
Hepatitis B
female genital diseases and pregnancy complications
Europe
Infectious Diseases
Geography
Population Surveillance
Tropical medicine
behavior and behavior mechanisms
population characteristics
030211 gastroenterology & hepatology
Birth cohort
geographic locations
Research Article
Demography
Zdroj: BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-14 (2018)
BMC Infectious Diseases, 18:34. BioMed Central Ltd.
BMC Infectious Diseases
ISSN: 1471-2334
DOI: 10.1186/s12879-017-2921-8
Popis: Background Chronic hepatitis B (CHB) related morbidity and mortality can be reduced through risk group screening, linkage to care and anti-viral treatment. This study estimates the number of CHB cases among foreign-born (migrants) in the European Union and European Economic Area (EU/EEA) countries in order to identify the most affected migrant populations. Methods The CHB burden was estimated by combining: demographic data on migrant population size by country of birth in the EU/EEA, extracted from European statistical databases; and CHB prevalence in migrants’ countries of birth and in EU/EEA countries, derived from a systematic literature search. The relative contribution of migrants from endemic countries to the total CHB burden in each country was also estimated. The reliability of using country of birth prevalence as a proxy for prevalence among migrants was assessed by comparing it to the prevalence found in studies among migrants in Europe. Results An estimated 1–1.9 million CHB-infected migrants from endemic countries (prevalence ≥2%) reside in the EU/EEA. Migrants from endemic countries comprise 10.3% of the total EU/EEA population but account for 25% (15%–35%) of all CHB cases. Migrants born in China and Romania contribute the largest number of infections, with over 100,000 estimated CHB cases each, followed by migrants from Turkey, Albania and Russia, in descending order, with over 50,000 estimated CHB cases each. The CHB prevalence reported in studies among migrants in EU/EEA countries was lower than the country of birth prevalence in 9 of 14 studies. Conclusions Migrants from endemic countries are disproportionately affected by CHB; their contribution however varies between EU/EEA countries. Migrant focused screening strategies would be most effective in countries with a high relative contribution of migrants and a low general population prevalence. In countries with a higher general population prevalence and a lower relative contribution of migrants, screening specific birth cohorts may be a more effective use of scarce resources. Quantifying the number of CHB infections among 50 different migrant groups residing in each of the 31 EU/EEA host countries helps to identify the most affected migrant communities who would benefit from targeted screening and linkage to care.
Databáze: OpenAIRE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje